These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8794887)

  • 21. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
    Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
    Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL60 cells resistant to 1-beta-D-arabinofuranosylcytosine.
    Kolla SS; Studzinski GP
    Cancer Res; 1994 Mar; 54(6):1418-21. PubMed ID: 8137241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
    Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
    Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
    Krysan K; Lou MF
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
    Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
    Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
    Toualbi K; Güller MC; Mauriz JL; Labalette C; Buendia MA; Mauviel A; Bernuau D
    Oncogene; 2007 May; 26(24):3492-502. PubMed ID: 17146436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C.
    Ivorra C; Kubicek M; González JM; Sanz-González SM; Alvarez-Barrientos A; O'Connor JE; Burke B; Andrés V
    Genes Dev; 2006 Feb; 20(3):307-20. PubMed ID: 16452503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
    Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
    Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues.
    Park CH; Lee JH; Yang CH
    J Biochem Mol Biol; 2005 Jul; 38(4):474-80. PubMed ID: 16053715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding.
    Ordway JM; Eberhart D; Curran T
    Mol Cell Biol; 2003 Jun; 23(12):4257-66. PubMed ID: 12773568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms.
    Wadhwa S; Mumper RJ
    Cancer Lett; 2013 Aug; 337(1):8-21. PubMed ID: 23727371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer.
    Dickinson SE; Melton TF; Olson ER; Zhang J; Saboda K; Bowden GT
    Cancer Res; 2009 Sep; 69(17):7103-10. PubMed ID: 19671797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the influence of thiols on lymphocytes (T-type lymphocytes) functions.
    Krzystyniak K; Ryzewski J; Chwaliński S
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):367-70. PubMed ID: 312073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes.
    Yamanaka H; Hakoda M; Kamatani N; Kashiwazaki S; Carson DA
    Immunopharmacology; 1993; 26(2):113-8. PubMed ID: 8282535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on D-penicillamine (1): Inhibitory effect of D-penicillamine on the heat-Cu++ induced denaturation of human gamma-globulin (author's transl)].
    Otomo S; Takahashi K; Sasajima M; Tanaka I
    Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):193-205. PubMed ID: 77827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factors AP-1 and NF-kappa B: where steroids meet the gold standard of anti-rheumatic drugs.
    Handel ML
    Inflamm Res; 1997 Aug; 46(8):282-6. PubMed ID: 9297571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.